CSIMarket Company Name, Ticker, Suppliers, else..
 
Spyre Therapeutics Inc   (NASDAQ: SYRE)
 
Price: $90.7550 $1.77 1.995%
Day's High: $91.13500213623047 Week Perf: 2.55 %
Day's Low: $ 85.00 30 Day Perf: -13.49 %
Volume (M): 398,613 52 Wk High: $ 110.18
Volume (M$): $ 0 52 Wk Avg: $53.70
Open: $85.00 52 Wk Low: $14.51



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 102
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -179
 Cash Flow (TTM) (Millions $) 16
 Capital Exp. (TTM) (Millions $) 0

Business Description


Spyre Therapeutics, Inc. is a clinical-stage biotechnology company developing long-acting antibodies and antibody combinations for the treatment of inflammatory bowel disease (IBD) and rheumatic diseases. Its pipeline includes engineered antibodies targeting α4β7, TL1A, and IL-23, designed for enhanced potency, selectivity, and extended half-life, focusing on both monotherapies and combination therapies. The company also plans to expand its anti-TL1A program to additional indications, including rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis.


   Company Address: 221 Crescent Street Waltham 2453 MA
   Company Phone Number: 651-5940   Stock Exchange / Ticker: NASDAQ SYRE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARVN   -0.22%    
MGNX        8.15% 
PFE   -1.55%    
SNDX        5.75% 
TEVA   -0.36%    
VTRS        1.15% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 28.48
Working Capital Ratio 29.2
Leverage Ratio (MRQ) 0.07
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -187.41 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,754,098
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.